Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
Clinical trial NCT03121001 · RECRUITING
Trial details
- NCT number
- NCT03121001
- Sponsor
- University of Illinois at Chicago
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2029-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.